Christine Stephens

University of Birmingham - Institute of Immunology and Immunotherapy

Birmingham

United Kingdom

SCHOLARLY PAPERS

2

DOWNLOADS
Rank 32,709

SSRN RANKINGS

Top 32,709

in Total Papers Downloads

1,821

SSRN CITATIONS

2

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

BNT162b2 Vaccination in People Over 80 Years of Age Induces Strong Humoral Immune Responses with Cross Neutralisation of P.1 Brazilian Variant

Number of pages: 24 Posted: 31 Mar 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, Quinton and Harborne PCN, University of Birmingham - Institute of Immunology and Immunotherapy, Deparment of Buisness Energy and Industrial Strategy - Vaccine Taskforce, Public Health England, Public Health England - Immunisation and Countermeasures Division, Public Health England - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Public Health England, Public Health England - National infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Public Health England - National Infection Service, Oxford Immunotec LTD, University of Birmingham - Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 1,082 (24,719)

Abstract:

Loading...

Vaccination. SARS-CoV-2. COVID. Immunosenescence. Antibody. T-cell. Variant. Neutralisation. Ageing. Immunisation

2.

Antibody Responses After First and Second COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukaemia

Number of pages: 23 Posted: 25 May 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Applied Health Research, Public Health England - National infection Service, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, Leeds Teaching Hospitals NHS Trust - St. James’s University Hospital, University Hospitals Birmingham - Queen Elizabeth Hospital, University Hospitals Birmingham - Birmingham Heartlands Hospital, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 739 (42,178)
Citation 1

Abstract:

Loading...

Vaccination; CLL; Leukaemia; SARS-CoV-2; COVID; Antibody